ClinicalTrials.gov
public full text
Public Domain
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
The prevalence of thyroid cancer has increased in recent decades. Patients with thyroid cancer need to choose between Thyrogen® injection and Eltroxin® withdrawal before radioiodine therapy or scan. This is a prospective, observational study, aiming to observe the difference of metabolic profiles between patients choose Thyrogen® injection and Eltroxin® withdrawal.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Levothyroxine Treatment in Thyroid Benign Nodular Goiter#891453
- Long-Term Efficacy and Safety of Once-Weekly Levothyroxine Regimen in Hypothyroid Patients#905257
- A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation#1338748
- The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance#897683
- Clinical Diagnostic Approach for Cases of Thyroid Nodules#1306987
Record · ID 1338685
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive